A detailed history of Harrell Investment Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Harrell Investment Partners, LLC holds 3,613 shares of DXCM stock, worth $239,650. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,613
Previous 5,316 32.04%
Holding current value
$239,650
Previous $413 Million 40.32%
% of portfolio
0.07%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

SELL
$67.74 - $90.75 $115,361 - $154,547
-1,703 Reduced 32.04%
3,613 $247 Million
Q4 2024

Jan 21, 2025

SELL
$65.68 - $81.01 $535,817 - $660,879
-8,158 Reduced 60.55%
5,316 $413 Million
Q3 2024

Oct 11, 2024

BUY
$64.0 - $116.06 $86,784 - $157,377
1,356 Added 11.19%
13,474 $903 Million
Q2 2024

Jul 18, 2024

BUY
$110.31 - $140.45 $75,231 - $95,786
682 Added 5.96%
12,118 $1.37 Billion
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $1.31 Million - $1.6 Million
11,436 New
11,436 $1.59 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Harrell Investment Partners, LLC Portfolio

Follow Harrell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harrell Investment Partners, LLC with notifications on news.